Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization
Journal of Virology · 2023
DOI: 10.1128/jvi.01604-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2023. Verfasst von Mallika Sastry und 37 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: HIV Seropositivity, AIDS Vaccines, HIV-1, HIV Infections. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
The HIV-1 fusion peptide has been identified as a site for elicitation of broadly neutralizing antibodies, with prior studies demonstrating that priming with fusion peptide-based immunogens and boosting with soluble envelope (Env) trimers can elicit cross-clade HIV-1-neutralizing responses. To improve the neutralizing breadth and potency of fusion peptide-directed responses, we evaluated vaccine regimens that incorporated diverse fusion peptide-conjugates and Env trimers with variation in fusion peptide length and sequence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA.
- Electron Microscopy Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, USA.
- Genscript USA, Piscataway, New Jersey, USA.
ORCID-Profile: Tongqing Zhou, Danealle K Parchment, Peter D Kwong
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- Intramural NIH HHS
- NIGMS NIH HHS
- CCR NIH HHS
- Vaccine Research Center
Zitieren
APA
Sastry, M., Changela, A., Gorman, J., Xu, K., Chuang, G. Y., Shen, C. H., Cheng, C., Geng, H., O'Dell, S., Ou, L., Rawi, R., Reveiz, M., Stewart-Jones, G. B. E., Wang, S., Zhang, B., Zhou, T., Biju, A., Chambers, M., Chen, X., …, & Kwong, P. D. (2023). Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization. Journal of Virology. https://doi.org/10.1128/jvi.01604-22
Vancouver
Sastry M, Changela A, Gorman J, Xu K, Chuang GY, Shen CH, et al. Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization. Journal of Virology. 2023. doi:10.1128/jvi.01604-22
BibTeX
@article{Sastry2023,
author = {Sastry, Mallika and Changela, Anita and Gorman, Jason and Xu, Kai and Chuang, Gwo-Yu and Shen, Chen-Hsiang and Cheng, Cheng and Geng, Hui and O'Dell, Sijy and Ou, Li and Rawi, Reda and Reveiz, Mateo and Stewart-Jones, Guillaume B E and Wang, Shuishu and Zhang, Baoshan and Zhou, Tongqing and Biju, Andrea and Chambers, Michael and Chen, Xuejun and Corrigan, Angela R and Lin, Bob C and Louder, Mark K and McKee, Krisha and Nazzari, Alexandra F and Olia, Adam S and Parchment, Danealle K and Sarfo, Edward K and Stephens, Tyler and Stuckey, Jonathan and Tsybovsky, Yaroslav and Verardi, Raffaello and Wang, Yiran and Zheng, Cheng-Yan and Chen, Yuling and Doria-Rose, Nicole A and McDermott, Adrian B and Mascola, John R and Kwong, Peter D},
title = {Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization},
journal = {Journal of Virology},
year = {2023},
doi = {10.1128/jvi.01604-22}
}
EUVIMED